Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers
口服小分子丝裂原活化蛋白激酶激酶1/2抑制剂AZD6244(ARRY-142886)在晚期癌症患者中的I期药代动力学和药效学研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2007.14.4956
Adjei, Alex A; Cohen, Roger B; Franklin, Wilbur; Morris, Clive; Wilson, David; Molina, Julian R; Hanson, Lorelei J; Gore, Lia; Chow, Laura; Leong, Stephen; Maloney, Lara; Gordon, Gilad; Simmons, Heidi; Marlow, Allison; Litwiler, Kevin; Brown, Suzy; Poch, Gregory; Kane, Katie; Haney, Jerry; Eckhardt, S Gail